Gene · 22806
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular parameters shaping pathways of targeted protein degradation. | Commun Biol | 2025 | 40316744 | PubTator, text mining | PubMed |
| Identification of E3 Ubiquitin Ligase Substrates Using Biotin Ligase-Based Proximity Labeling Approaches. | Biomedicines | 2025 | 40299435 | PubTator, text mining | PubMed |
| Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy. | Mol Ther Oncol | 2025 | 40231187 | PubTator, text mining | PubMed |
| Prognostic value of natural killer T cell related genes in acute myeloid leukemia. | Cancer Cell Int | 2025 | 40223063 | PubTator, text mining | PubMed |
| Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2-Mediated Transcriptional Network in Multiple Myeloma. | Adv Sci (Weinh) | 2025 | 40167268 | PubTator, text mining | PubMed |
| Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs. | Mol Ther Oncol | 2025 | 40123976 | PubTator, text mining | PubMed |
| Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy. | Expert Opin Ther Targets | 2025 | 40122131 | PubTator, text mining | PubMed |
| Author Correction: Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development. | Nat Immunol | 2025 | 40119193 | PubTator, text mining | PubMed |
| Comprehensive profiling of T-cell exhaustion signatures and establishment of a prognostic model in lung adenocarcinoma through integrated RNA-sequencing analysis. | Technol Health Care | 2025 | 40105167 | PubTator, text mining | PubMed |
| Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability. | J Med Chem | 2025 | 40063353 | PubTator, text mining | PubMed |
| Responsiveness of systemic lupus erythematosus subjects to iberdomide based on molecular endotypes. | Ann Rheum Dis | 2025 | 40021405 | PubTator, text mining | PubMed |
| Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir. | J Virol | 2025 | 39902962 | PubTator, text mining | PubMed |
| The histone demethylase KDM5C enhances the sensitivity of acute myeloid leukemia cells to lenalidomide by stabilizing cereblon. | Cell Mol Biol Lett | 2025 | 39881283 | PubTator, text mining | PubMed |
| Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs. | ACS Pharmacol Transl Sci | 2025 | 39816802 | PubTator, text mining | PubMed |
| All-In-One Entropy-Driven DNA Nanomachine for Tumor Cell-Selective Fluorescence/SERS Dual-Mode Imaging of MicroRNA. | Anal Chem | 2025 | 39806536 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: A randomized phase 2 clinical trial. | J Am Acad Dermatol | 2025 | 39461504 | PubTator, text mining | PubMed |
| Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression. | Blood | 2025 | 39437550 | PubTator, text mining | PubMed |
| Polymorphisms within genes encoding Ikaros family proteins IKZF1 and IKZF3 in multiple myeloma patients treated with thalidomide. | Dent Med Probl | 2024 | 39704419 | PubTator, text mining | PubMed |
| Increased CSN5 expression enhances the sensitivity to lenalidomide in multiple myeloma cells. | iScience | 2024 | 39687025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22806/papers?page=5